Research & Initiatives

Development Updates: Point-of-Care Diagnostics for Pulmonary TB

 

Advancing Rapid, Accessible TB Detection

​

Pulmonary tuberculosis remains one of the world’s most pressing infectious diseases, with delayed diagnosis continuing to drive transmission and mortality. At the intersection of innovation and accessibility, our team is developing a next-generation point-of-care diagnostic platform designed to deliver fast, accurate results in resource-limited settings.

 

🚀 Key Development Highlights

​

Prototype Development Completed

We have successfully developed and validated our first working prototype, designed for rapid detection of pulmonary TB at the point of care. The device integrates a streamlined workflow, enabling testing with minimal infrastructure and training.

​

Enhanced Sensitivity and Specificity

Our assay development efforts are focused on achieving high sensitivity for early-stage detection, while maintaining strong specificity to reduce false positives. Ongoing optimization is delivering promising laboratory results.

​

Sample-to-Answer Integration

The platform is being engineered as a fully integrated “sample-to-answer” system, reducing the need for complex laboratory processing and enabling results within a clinically actionable timeframe.

 

🔬 Ongoing Research & Validation

​

Technology Optimization

Current efforts are focused on improving assay stability, reducing turnaround time, and enhancing portability to ensure usability in decentralized healthcare settings.